Ethnopharmacological relevance Spermacoce stachydea (Rubiaceae) is traditionally used for malaria treatment, yet its phytochemical composition, antioxidant properties, antiplasmodial activity, and safety profile remain insufficiently characterised. This study aimed to provide a comprehensive preclinical validation of its ethnomedicinal use.Methods The whole-plant methanolic extract was profiled by UHPLC-HRMS and GC–MS. Total phenolic (TPC), flavonoid (TFC), and condensed tannin (CTC) contents were quantified, and antioxidant capacity was assessed by DPPH, ABTS, FRAP, and ORAC assays. Antiplasmodial activity was evaluated in vitro against Plasmodium falciparum and in vivo in P. berghei ANKA-infected NMRI mice using suppressive, curative, and prophylactic models. Host-protective effects and safety were assessed through physiological, haematological, biochemical, and histopathological analyses in accordance with OECD guidelines.Results Phytochemical profiling revealed a diverse array of bioactive metabolites including flavonoids, terpenoids, coumarins, iridoids, alkaloids, and polyphenols. The extract exhibited a flavonoid-dominant phenolic profile (TPC: 33.99 ± 0.07 mg GAE/100 mg; TFC: 7.57 ± 0.03 mg QE/100 mg) and strong DPPH radical scavenging activity (774 ± 3.9 µmol AAE/g), comparable to Trolox and superior to quercetin. In vitro antiplasmodial activity was significant (IC₅₀ = 6.30 ± 0.13 µg/mL) with negligible haemolysis ( 5000 mg/kg) and 2000 mg/kg/day (subacute; NOAEL > 2000 mg/kg/day). The extract exhibited low toxicity, with an oral LD₅₀ > 5000 mg/kg and a subacute NOAEL of 2000 mg/kg.Conclusion S. stachydea demonstrated significant antiplasmodial, antioxidant, and host-protective activities with a favourable safety profile, validating its traditional use in malaria management and supporting its potential as a source of multitarget antimalarial compounds.